Resistome phylodynamics of multidrug-resistant Shigella isolated from diarrheal patients

Asaduzzaman Asad1, Md Abu Jaher Nayeem1, Md Golam Mostafa1

  • 1Gut-Brain Axis Laboratory, Infectious Diseases Division (IDD), icddr, b, Dhaka, Bangladesh.

Microbiology Spectrum
|November 29, 2024
PubMed

Insights

Multi-drug resistant Shigella in Bangladesh poses a public health threat. Genomic analysis revealed emerging resistance genes on plasmids, linked to global strains, highlighting urgent containment needs.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Multi-drug resistance (MDR) in Shigella is a critical global health issue, especially in developing nations.
  • Genomic surveillance aids in understanding antimicrobial resistance (AMR) but data on Shigella resistome dynamics in Bangladesh is limited.

Purpose of the Study:

  • To investigate the dynamics of MDR Shigella resistomes in Bangladesh.
  • To evaluate the transmission patterns and phylodynamics of AMR in Shigella strains.

Main Methods:

  • Phenotypic screening of clinical Shigella strains for MDR using antibiotic susceptibility tests.
  • Whole-genome sequencing (WGS) and bioinformatics analysis of Shigella isolates.
  • Comparative analysis with global plasmid and resistance gene databases.

Main Results:

  • Identified 28 distinct antimicrobial resistance genes (ARGs) in Shigella, with 75% located on plasmids.
  • Discovered novel conjugative MDR plasmids and mobile genomic islands carrying resistance genes, including those for first-line shigellosis treatments.
  • Phylogenetic analysis revealed links between Bangladeshi MDR Shigella and isolates from Europe, USA, and China, suggesting global ARG transmission.

Conclusions:

  • Emerging MDR plasmids and genomic islands in Shigella from Bangladesh are linked to international sources.
  • Horizontal propagation of ARGs among enteropathogens necessitates enhanced AMR containment strategies.
  • Phylodynamic insights are crucial for informing treatment decisions and public health policies to combat AMR.